Table 1.

Characteristics of the patients included in the MATCH-R trial

		Patients with at least one biopsy (n = 857)
Age at inclusion	Mean (SD)	61.8 (12.2)
	Median (IQR)	63.3 (54.7—70.5)
	Min—Max	22—93
Gender	Male	480 (56.0%)
	Female	377 (44.0%)
Primary tumor type	Lung	333 (38.9%)
	Digestive	140 (16.3%)
	Prostate	121 (14.1%)
	Urothelial	86 (10.0%)
	Gynecological	50 (5.8%)
	Other	34 (4.0%)
	Hematological	28 (3.3%)
	Head and neck	21 (2.5%)
	Sarcoma	20 (2.3%)
	Breast	16 (1.9%)
	Skin	8 (0.9%)
Type of treatment received	Targeted therapy	265 (30.9%)
	Immunotherapy	165 (19.3%)
	Endocrine therapy	121 (14.1%)
	Other	306 (35.7%)